Anantha Gollapudi

Statistics

Publications

Citations

156

H-Index

Active since

2012

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Anantha Gollapudi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, life sciences, and medicinal chemistry.

Publications per year

2012–2020

Publications

1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia

Petr Váchal, Shouwu Miao, Joan M. Pierce et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase

Danqing Feng, Tesfaye Biftu, F. Anthony Romero et al. · ACS Medicinal Chemistry Letters · 2017 · 62 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14

Age-associated changes in the circulating human antibody repertoire are upregulated in autoimmunity

Aaron Arvey, M.T. Rowe, Joseph Barten Legutki et al. · Immunity & Ageing · 2020 · 28 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

1–3 of 3